Search Results
Aug 25, 2026, 09:00 ET SandboxAQ Accelerates Fortune 500 Catalyst Discovery with AQCat, Now Generally Available in AWS Marketplace
candidate materials computationally, then reserving costly laboratory and supercomputing work for only the strongest leads. This allows users to compress R&D timelines and de-risk investment across the pipeline.Making AQCat generally available in AWS Marketplace marks a shift from bespoke scientific
More news about: SandboxAQ
Aug 25, 2026, 09:00 ET Schoox Customers Win Gold for Learning Programs Built to Drive Change at 2026 Brandon Hall Group HCM Excellence Awards
outcomes against operational KPIs. And uniquely, we forecast the expected return of a training investment before a program ever launches. The result: L&D that operates not as a cost center, but as a measurable driver of enterprise performance.In addition to Copper's Hawk Winery & Restaurants
More news about: Schoox LLC
Aug 25, 2026, 08:45 ET WuXi Biologics Reports Strong Profitable Growth in H1 2026
worldwide*.With over 14,000 employees in China, the United States, Ireland, Germany, and Singapore, including experts and scientists in biologics R&D and manufacturing, technology innovation, and operational excellence, WuXi Biologics leverages its technologies and expertise to deliver efficient,
More news about: WuXi Biologics
Aug 25, 2026, 08:44 ET Switch Bioworks Names Gordana M. Djordjevic Chief Scientific Officer, Adds Eric Bartels to Advisory Board
establish its R&D infrastructure, IP and early commercial pipelines. As Vice President of R&D at Perfect Day, she led multidisciplinary teams across strain engineering, high-throughput screening, fermentation, automation, bioanalytics and data science. Her leadership drove critical R&D efficiency
More news about: Switch Bioworks
Aug 25, 2026, 08:44 ET Fosun Pharma Announces 2026 Interim Results
in-house R&D, two-way licensing and fund-incubation models, the Company accelerates clinical translation and pushes forward its innovation-led transformation.In 1H2026, Fosun Pharma's total R&D investment amounted to RMB 3.247 billion, up 25.66% year-on-year. Among this, R&D investment
More news about: Fosun Pharma
Aug 25, 2026, 08:41 ET Christian Author Justin Kase Warns: Self-Aware AI Will Either Serve or Destroy Us If It Learns Survival of the Fittest
https://a.co/d/006wnb6xMedia Contact:Justin [email protected]
More news about: Justin Kase
Aug 25, 2026, 08:32 ET 유틸리티 글로벌, 독자적 H2Gen 상업화 추진을 위해 에릭 뮬레만을 최고 기술 책임자로 영입
multimedia:https://www.prnewswire.com/kr/news-releases/uC720uD2F8uB9ACuD2F0u002DuAE00uB85CuBC8Cu002Cu002DuB3C5uC790uC801u002Du0068u0032u0067u0065u006Eu002DuC0C1uC5C5uD654u002DuCD94uC9C4uC744u002D-302859174.htmlSOURCE
More news about: Utility Global
Aug 25, 2026, 08:32 ET TeamSnap and XbotGo's Integrated Live Streaming Experience Is Now Available to All TeamSnap ONE Users
accessible to all through AI. Today, XbotGo is a global AI sports technology company owned by Blink Tech, headquartered in Silicon Valley, California, with R&D centers across Silicon Valley, Beijing, Shenzhen, and Suzhou. Combining world-class AI expertise with global innovation and manufacturing capabilities,
More news about: TeamSnap
Aug 25, 2026, 08:31 ET A $1,500 iPhone Just Outran a $50,000 Lab Bench - On Camera, Unscripted, Independently Verified
www.FreqCheck.com Rogá(Romuald Gawlik)Founder and CEOROGA-InstrumentsIm Hasenacker 56D-56412 NentershausenTel: +49 (0) 6485 8815803Fax: +49 (0) 6485 8818373
More news about: FreqCheck™
Aug 25, 2026, 08:30 ET ECAM Encourages Multifamily Operators to Consider Live Video Monitoring as They Enter Budget Season Facing Heightened Crime Scrutiny from Insurers and Residents
advanced AI-driven live video surveillance technology with human expertise to deliver real-time protection with unmatched precision and vigilance. From R&D to product development and platform innovation, ECAM fully owns and develops its entire operation and technology stack. The company develops proprietary
More news about: ECAM
Aug 25, 2026, 08:17 ET Red Robin Partners with The Faris Foundation to Make Mealtime Matter This September
Red Robin's partnership and the support of its guests," said Dr. Asha Virani, co-founder and "Mommy" to the Foundation's Chief Angel Officers, Faris D. Virani. "Together, we can create brighter days and advance better treatments for children with cancer while bringing comfort, hope and encouragement
More news about: Red Robin Gourmet Burgers, Inc.
Aug 25, 2026, 08:03 ET Zendure study shows: Regulations, rental agreements, and a perceived complicated installation process are slowing down the adoption of solar power
2025.About ZendureDriven by our purpose to accelerate a sustainable future, Zendure is a global pioneer of plug-in HEMS. With R&D and operations centers spanning major tech hubs like Silicon Valley and the Greater Bay Area, alongside Japan and Germany, our vision is to become
More news about: Zendure
Aug 25, 2026, 08:00 ET CPL Expands Science & Technology Leadership in Atlanta to Support the Southeast's Growing Innovation Economy
market sectors – providing architectural, interior design, civil engineering, buildings and structural engineering, planning, landscape architecture and 3D/virtual design services to a host of public and private clients. Visit www.CPLteam.com to learn more.
More news about: CPL Architecture | Engineering | Planning
Aug 25, 2026, 08:00 ET NO GRAY® EXPANDS ITS BREAKTHROUGH QUICK COLOR SHAMPOO® LINE WITH NEW MEDIUM BROWN SHADE
color correction and transformation to effortless gray coverage, empowering consumers with confidence, creativity, and control. Vertically integrated R&D, formulation, and manufacturing bring ideas to market with speed, precision, and consistent quality. Vegan-certified, cruelty-free, and proudly made
More news about: DEVELOPLUS, INC.
Aug 25, 2026, 08:00 ET CivicaScript® launches 3 low-cost generics to expand its market impact
https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/quarterly-prescription-drug-plan-formulary-pharmacy-network-and-pricing-information (Q1 2026)[4] Compared with 2017-2022 average commercial
More news about: Civica Rx
Aug 25, 2026, 08:00 ET Nota AI's Optimization Research Earns Global Recognition
the technical foundation needed to improve the efficiency of large language models and data center AI infrastructure. We will continue investing in R&D to keep pace with architectural changes in state-of-the-art AI models and expand the application of our core optimization technology to make AI infrastructure
More news about: Nota AI
Aug 25, 2026, 08:00 ET BLACK PEARL EXTENDS TENDER OFFER FOR ALL OUTSTANDING SHARES OF SELECTIS HEALTH, INC.
documents with the U.S. Securities and Exchange Commission (the "SEC"), and Selectis has filed a Solicitation/Recommendation Statement on Schedule 14D-9 relating to the tender offer with the SEC. Selectis' stockholders are strongly advised to read these tender offer materials carefully and in their
More news about: Black Pearl Equities
Aug 25, 2026, 08:00 ET 1 in 10 U.S. Babies Are Born Too Early. A Leading OB-GYN Says Most Mothers Can Learn Their Risk by Week 21, and Do Something About It.
10 U.S. pregnancies and is the leading cause of illness and death in newborns. In its 2025 Report Card, the March of Dimes gave the United States a "D+" for preterm birth for the fourth consecutive year.What tests should I ask my doctor about at my 20-week ultrasound?Your 20-week
More news about: Sera Prognostics Inc.
Aug 25, 2026, 08:00 ET Google Cloud Launches Gemini Enterprise for Financial Services
D&B Business Verification Agent to accelerate commercial onboarding and strengthen Know Your Customer (KYC) compliance;
More news about: Google Cloud
Aug 25, 2026, 07:45 ET Vascarta Outlines VAS-101's (Vasceptor®) Potential as a Non-Opioid Advance in Pain Medicine Across Sickle Cell Disease, Osteoarthritis, and Cancer
https://doi.org/10.1093/jscdis/yoag020.0033. Goel Y, Mireles C, Ordaz D, O'Daniel K, Peterson KA, Lomeli N, Lomeli R, Bota DA, Friedman J, Gupta K. Novel transdermal curcumin (VAS-101) attenuates cisplatin-induced neuropathy
More news about: Vascarta Inc.
Aug 25, 2026, 07:00 ET CLO Virtual Fashion Resolves Major US Patent Infringement Case, Secures Settlement Against Style3D
Virtual Fashion ("CLO"), the leading innovator in 3D garment design technologies, secured an agreement that concludes its U.S. patent infringement lawsuit against Zhejiang Lingdi Digital Technology Co., Ltd. (also known as Linctex), the company behind Style3D. The legal action, initiated in 2023, alleged that
More news about: CLO Virtual Fashion
Aug 25, 2026, 07:00 ET CLO Virtual Fashion Resolves Major US Patent Infringement Case, Secures Settlement Against Style3D
Virtual Fashion ("CLO"), the leading innovator in 3D garment design technologies, secured an agreement that concludes its U.S. patent infringement lawsuit against Zhejiang Lingdi Digital Technology Co., Ltd. (also known as Linctex), the company behind Style3D. The legal action, initiated in 2023, alleged
More news about: CLO Virtual Fashion
Aug 25, 2026, 07:00 ET 클로버추얼패션 , Style3D 를 상대로 한 주요 미국 특허 침해 소송에서 합의로 종결
/PRNewswire/ -- 3D 의상 디자인 기술을 선도하는 혁신 기업 클로버추얼패션 (" 클로 ") 이 Style3D 개발사인 Zhejiang Lingdi Digital Technology Co., Ltd.( 이하 "Linctex") 를 상대로 제기한 미국 특허 침해 소송을 합의로 종결했다 . 2023 년에 시작된 이 소송은 Linctex 가 클로의 특허 기술을 고의적으로 무단 사용했다고 주장하며 , 손해배상과 클로의 미국 특허 3 건에 대한 침해 금지 명령을 청구했다 . 이번 합의의 일환으로 , Linctex 는 문제가 된 Style3D Studio
More news about: CLO Virtual Fashion
Aug 25, 2026, 07:00 ET CLO Virtual Fashion resuelve un importante caso de infracción de patentes en EE. UU. y logra un acuerdo frente a Style3D
innovadora en tecnologías de diseño de prendas en 3D, ha alcanzado un acuerdo que pone fin a su demanda por infracción de patentes en los EE. UU. contra Zhejiang Lingdi Digital Technology Co., Ltd. (también conocida como Linctex), la empresa creadora de Style3D. La acción legal, iniciada en 2023, alegaba que
More news about: CLO Virtual Fashion
Aug 25, 2026, 07:00 ET CLO Virtual Fashion risolve un importante caso di violazione di brevetto negli Stati Uniti e ottiene un accordo nei confronti di Style3D
di progettazione di capi d'abbigliamento in 3D, ha raggiunto un accordo che conclude la propria causa per violazione di brevetto negli Stati Uniti contro Zhejiang Lingdi Digital Technology Co., Ltd. (nota anche come Linctex), l'azienda che sviluppa Style3D. L'azione legale, avviata nel 2023, sosteneva
More news about: CLO Virtual Fashion